Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
Recent: |
|
Past: |
|
In an overstretched health care system warped by business interests, a depression survey has become a crutch — used in place of, rather than as a gateway to, thoughtful care. → Read More
Health insurers are years away from covering psychedelics, but employers — eager to offer whatever perks might entice talent — may be poised to do so much sooner. → Read More
New findings of altered images in research co-authored by Stanford University president Marc Tessier-Lavigne add to the weight of allegations against him, according to experts on research misconduct. → Read More
Vaccine researcher Kathrin Jansen said at the #STATSummit that a flu pandemic is inevitable: “The question is, does it come tomorrow or 50 years from now?” → Read More
Colorado looks set to legalize magic mushrooms in this week’s midterm elections, with the group opposing the ballot question conceding defeat. → Read More
“Doctors fought hard for these rights because we’re sick of watching women die,” Melissa Bayne, an OB-GYN in Fremont, Mich., told the audience at a rally Saturday. → Read More
A response in patients with treatment-resistant depression is promising, though the effects of psilocybin were not as long-lasting as seen in earlier and smaller studies. → Read More
As a wave of abortion restrictions sweeps the U.S., medical schools and residency programs are struggling to ensure future doctors are adequately trained. → Read More
State laws criminalizing abortion have put physicians under intense scrutiny and made them fearful, with implications that extend well beyond abortion. → Read More
The Supreme Court decision overturning Roe v. Wade suggests other rights founded on the same principle of privacy, including gay sex, same-sex marriage, interracial marriage, and the freedom to use contraception, are now also called into question. → Read More
Even accounting for rich nations' booster shots, there’s ample supply of Covid vaccines to meet global vaccination goals for the end of 2021. → Read More
Overall, 29.1% of patients in the highest-dose group were in remission three weeks after treatment, compared to 7.6% in the control group. → Read More
The chief executive Athira Pharma left the company after papers she published as a student were found to contain altered research. → Read More
Conceived at the start of the pandemic, Covax pursued lofty goals, promising fair access to Covid-19 vaccines for every country worldwide, and to give them free to the poorest. → Read More
The global collaboration, set up early in the pandemic to give people in rich and poor nations equitable access to vaccines, has fallen short. → Read More
Three altered papers co-authored by former chief executive Leen Kawas were referenced in an Athira application for NIH funding. → Read More
“I hate that it closed,” Latasha Taylor said. “That doesn’t make a lot of sense. Why would you close a hospital in the middle of a pandemic?” → Read More
Vaccine drives intended for underserved communities became destinations for people who know whom to call and how to advocate for themselves. → Read More
The new vaccines could complicate an already-messy rollout. But their different features also open the door to greater convenience. → Read More
Tens of thousands of Covid-19 deaths are going unreported, with far more missed in counties that strongly supported former President Trump. → Read More